This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Benwell, M. E., & Balfour, D. J. (1992). The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity. British Journal of Pharmacology, 105(4), 849–856.
Bespalov, A. Y., Dravolina, O. A., Sukhanov, I., Zakharova, E., Blokhina, E., Zvartau, et al. (2005). Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue- and schedule-induced reinstatement of nicotine self-administration behavior in rats. Neuropharmacology, 49 Suppl, 167–178.
Bevins, R. A., Besheer, J., & Pickett, K. S. (2001). Nicotine-conditioned locomotor activity in rats: Dopaminergic and GABAergic influences on conditioned expression. Pharmacology, Biochemistry, and Behavior, 68(1), 135–145.
Bierut, L. J., Madden, P. A., Breslau, N., Johnson, E. O., Hatsukami, D., Pomerleau, O. F., et al. (2007). Novel genes identified in a high-density genome wide association study for nicotine dependence. Human Molecular Genetics, 16(1), 24–35.
Brody, A. L., Mandelkern, M. A., London, E. D., Childress, A. R., Lee, G. S., Bota, R. G., et al. (2002). Brain metabolic changes during cigarette craving. Archives of General Psychiatry, 59(12), 1162–1172.
Brody, A. L., Mandelkern, M. A., London, E. D., Olmstead, R. E., Farahi, J., Scheibal, D., et al. (2006). Cigarette smoking saturates brain alpha4 beta2 nicotinic acetylcholine receptors. Archives General Psychiatry, 63(8), 907–915.
Brody, A. L., Olmstead, R. E., London, E. D., Farahi, J., Meyer, J. H., Grossman, P., et al. (2004). Smoking-induced ventral striatum dopamine release. The American Journal of Psychiatry, 161(7), 1211–1218.
Brunzell, D. H., Chang, J. R., Schneider, B., Olausson, P., Taylor, J. R., & Picciotto, M. R. (2006). Beta2-subunit-containing nicotinic acetylcholine receptors are involved in nicotine-induced increases in conditioned reinforcement but not progressive ratio responding for food in C57BL/6 mice. Psychopharmacology (Berl), 184(3–4), 328–338.
Brunzell, D. H., & Picciotto, M. R. (2004). Non-biased nicotine conditioned place preference requires the beta2-subunit containing nicotinic acetylcholine receptors: Regulation of CREB as a potential mechanism for nicotine reinforcement. Paper presented at the Society for Neuroscience, 34th Annual Meeting, San Diego, California.
Brunzell, D. H., Russell, D. S., & Picciotto, M. R. (2003). In vivo nicotine treatment regulates mesocorticolimbic CREB and ERK signaling in C57BL/6 J mice. Journal Neurochemistry, 84(6), 1431–1441.
Cador, M., Taylor, J. R., & Robbins, T. W. (1991). Potentiation of the effects of reward-related stimuli by dopaminergic-dependent mechanisms in the nucleus accumbens. Psychopharmacology (Berl), 104(3), 377–385.
Caggiula, A. R., Donny, E. C., Chaudhri, N., Perkins, K. A., Evans-Martin, F. F., & Sved, A. F. (2002a). Importance of nonpharmacological factors in nicotine self-administration. Physiology & Behavior, 77(4–5), 683–687.
Caggiula, A. R., Donny, E. C., White, A. R., Chaudhri, N., Booth, S., Gharib, M. A., et al. (2001). Cue dependency of nicotine self-administration and smoking. Pharmacology, Biochemistry, and Behavior, 70(4), 515–530.
Caggiula, A. R., Donny, E. C., White, A. R., Chaudhri, N., Booth, S., Gharib, M. A., et al. (2002b). Environmental stimuli promote the acquisition of nicotine self-administration in rats. Psychopharmacology (Berl), 163(2), 230–237.
Champtiaux, N., Gotti, C., Cordero-Erausquin, M., David, D. J., Przybylski, C., Lena, C., et al. (2003). Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice. The Journal of Neuroscience, 23(21), 7820–7829.
Chang, K. T., & Berg, D. K. (2001). Voltage-gated channels block nicotinic regulation of CREB phosphorylation and gene expression in neurons. Neuron, 32(5), 855–865.
Changeux, J. P., Devillers-Thiery, A., & Chemouilli, P. (1984). Acetylcholine receptor: An allosteric protein. Science, 225(4668), 1335–1345.
Cohen, C., Perrault, G., Griebel, G., & Soubrie, P. (2005). Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: Reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716). Neuropsychopharmacology, 30(1), 145–155.
Corrigall, W. A., Coen, K. M., & Adamson, K. L. (1994). Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Research, 653(1–2), 278–284.
Corrigall, W. A., Franklin, K. B., Coen, K. M., & Clarke, P. B. (1992). The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology (Berl), 107(2–3), 285–289.
Cui, C., Booker, T. K., Allen, R. S., Grady, S. R., Whiteaker, P., Marks, M. J., et al. (2003). The beta3 nicotinic receptor subunit: A component of alpha-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors. The Journal Neuroscience, 23(35), 11045–11053.
Davis, J. A., & Gould, T. J. (2006). The effects of DhbE and MLA on nicotine-induced enhancement of contextual fear conditioning in C57BL/6 mice. Psychopharmacology (Berl), 184, 345–352.
Davis, J. A., & Gould, T. J. (2007). Beta2 subunit-containing nicotinic receptors mediate the enhancing effect of nicotine on trace cued fear conditioning in C57BL/6 mice. Psychopharmacology (Berl), 190(3), 343–352.
Di Chiara, G., & Imperato, A. (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proceedings of the National Acadamey of Science of the United States of America, 85(14), 5274–5278.
Dineley, K. T., Westerman, M., Bui, D., Bell, K., Ashe, K. H., & Sweatt, J. D. (2001). Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to alzheimer's disease. The Journal Neuroscience, 21(12), 4125–4133.
Due, D. L., Huettel, S. A., Hall, W. G., & Rubin, D. C. (2002). Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: Evidence from functional magnetic resonance imaging. American Journal of Psychiatry, 159(6), 954–960.
Ferrari, R., Le Novere, N., Picciotto, M. R., Changeux, J. P., & Zoli, M. (2002). Acute and long-term changes in the mesolimbic dopamine pathway after systemic or local single nicotine injections. European Jpurnal of Neuroscience, 15(11), 1810–1818.
Franklin, T. R., Wang, Z., Wang, J., Sciortino, N., Harper, D., Li, Y., Ehrman, R., et al. (2007). Limbic activation to cigarette smoking cues independent of nicotine withdrawal: A perfusion fMRI study. Neuropsychopharmacology, 32(11), 2301–2309.
Gaddnas, H., Pietila, K., & Ahtee, L. (2000). Effects of chronic oral nicotine treatment and its withdrawal on locomotor activity and brain monoamines in mice. Behavioural Brain Research, 113(1–2), 65–72.
Gozzi, A., Schwarz, A., Reese, T., Bertani, S., Crestan, V., & Bifone, A. (2005). Region-specific effects of nicotine on brain activity: A pharmacological MRI study in the drug-naive rat. Neuropsychopharmacology, 31(8), 1690–1703.
Grady, S., Marks, M. J., Wonnacott, S., & Collins, A. C. (1992). Characterization of nicotinic receptor-mediated [3 H]dopamine release from synaptosomes prepared from mouse striatum. The Journal Neurochemistry, 59(3), 848–856.
Grady, S. R., Marks, M. J., & Collins, A. C. (1994). Desensitization of nicotine-stimulated [3 h]dopamine release from mouse striatal synaptosomes. The Journal Neurochemistry, 62(4), 1390–1398.
Grady, S. R., Meinerz, N. M., Cao, J., Reynolds, A. M., Picciotto, M. R., Changeux, J. P., et al. (2001). Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: A function mediated by a different nachr than dopamine release from striatum. The Journal Neurochemistry, 76(1), 258–268.
Greengard, P. (2001). The neurobiology of slow synaptic transmission. Science, 294(5544), 1024–1030.
Grenhoff, J., Aston-Jones, G., & Svensson, T. H. (1986). Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiologica Scandinavica, 128(3), 351–358.
Grottick, A. J., Trube, G., Corrigall, W. A., Huwyler, J., Malherbe, P., Wyler, R., et al. (2000). Evidence that nicotinic alpha7 receptors are not involved in the hyperlocomotor and rewarding effects of nicotine. The Journal of Pharmacology and Experimental Therapeutics, 294(3), 1112–1119.
Hope, B. T., Nagarkar, D., Leonard, S., & Wise, R. A. (2007). Long-term upregulation of protein kinase A and adenylate cyclase levels in human smokers. The Journal of Neuroscience, 27(8), 1964–1972.
Jentsch, J. D., & Taylor, J. R. (1999). Impulsivity resulting from frontostriatal dysfunction in drug abuse: Implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl), 146(4), 373–390.
Kelley, A. E. (2004). Memory and addiction: Shared neural circuitry and molecular mechanisms. Neuron, 44(1), 161–179.
Kelley, A. E. (2006). Worms clear the smoke surrounding nicotine addiction. Cell, 127(3), 460–462.
King, S. L., Caldarone, B. J., & Picciotto, M. R. (2004). Beta2-subunit-containing nicotinic acetylcholine receptors are critical for dopamine-dependent locomotor activation following repeated nicotine administration. Neuropharmacology, 47(Suppl 1), 132–139.
Klink, R., de Kerchove d'Exaerde, A., Zoli, M., & Changeux, J. P. (2001). Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. The Journal of Neuroscience, 21(5), 1452–1463.
Kulak, J. M., Sum, J., Musachio, J. L., McIntosh, J. M., & Quik, M. (2002). 5-iodo-A-85380 binds to alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors (nAChRs) as well as alpha4beta2* subtypes. The Journal of Neurochemistry, 81(2), 403–406.
Lai, A., Parameswaran, N., Khwaja, M., Whiteaker, P., Lindstrom, J. M., Fan, H., et al. (2005). Long-term nicotine treatment decreases striatal alpha6* nicotinic acetylcholine receptor sites and function in mice. Molecular Pharmacology, 67(5), 1639–1647.
Laviolette, S. R., & van der Kooy, D. (2003). The motivational valence of nicotine in the rat ventral tegmental area is switched from rewarding to aversive following blockade of the alpha7-subunit-containing nicotinic acetylcholine receptor. Psychopharmacology (Berl), 166(3), 306–313.
Le Foll, B., Diaz, J., & Sokoloff, P. (2003). Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats. Synapse, 47(3), 176–183.
Le Foll, B., Schwartz, J. C., & Sokoloff, P. (2003). Disruption of nicotine conditioning by dopamine D3 receptor ligands. Molecular Psychiatry, 8(2), 225–230.
Le Foll, B., Sokoloff, P., Stark, H., & Goldberg, S. R. (2005). Dopamine D3 receptor ligands block nicotine-induced conditioned place preferences through a mechanism that does not involve discriminative-stimulus or antidepressant-like effects. Neuropsychopharmacology, 30(4), 720–730.
le Novere, N., Zoli, M., Lena, C., Ferrari, R., Picciotto, M. R., Merlo-Pich, E., et al. (1999). Involvement of alpha6 nicotinic receptor subunit in nicotine-elicited locomotion, demonstrated by in vivo antisense oligonucleotide infusion. Neuroreport, 10(12), 2497–2501.
Lesage, M. G., Burroughs, D., Dufek, M., Keyler, D. E., & Pentel, P. R. (2004). Reinstatement of nicotine self-administration in rats by presentation of nicotine-paired stimuli, but not nicotine priming. Pharmacology, Biochemistry, and Behavior, 79(3), 507–513.
Liu, X., Koren, A. O., Yee, S. K., Pechnick, R. N., Poland, R. E., & London, E. D. (2003). Self-administration of 5-iodo-A-85380, a beta2-selective nicotinic receptor ligand, by operantly trained rats. Neuroreport, 14(11), 1503–1505.
Mansvelder, H. D., Keath, J. R., & McGehee, D. S. (2002). Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron, 33(6), 905–919.
Markou, A., & Paterson, N. E. (2001). The nicotinic antagonist methyllycaconitine has differential effects on nicotine self-administration and nicotine withdrawal in the rat. Nicotine & Tobacco Research, 3(4), 361–373.
Marubio, L. M., Gardier, A. M., Durier, S., David, D., Klink, R., Arroyo-Jimenez, M. M., et al. (2003). Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors. European Journal of Neuroscience, 17(7), 1329–1337.
Maskos, U., Molles, B. E., Pons, S., Besson, M., Guiard, B. P., Guilloux, J. P., et al. (2005). Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature, 436(7047), 103–107.
McCallum, S., Parameswaran, N., Bordia, T., Fan, H., McIntosh, M., & Quik, M. (2006). Differential regulation of mesolimbic alpha3*/alpha6beta2* and alpha4beta2* nAChR sites and function after long-term oral nicotine to monkeys. The Journal Pharmacology and Experimental Therapeutics, 318(1), 381–388.
Middleton, L. S., Cass, W. A., & Dwoskin, L. P. (2004). Nicotinic receptor modulation of dopamine transporter function in rat striatum and medial prefrontal cortex. The Journal Pharmacology and Experimental Therapeutics, 308(1), 367–377.
Mogg, A. J., Whiteaker, P., McIntosh, J. M., Marks, M., Collins, A. C., & Wonnacott, S. (2002). Methyllycaconitine is a potent antagonist of alpha-conotoxin MII-sensitive presynaptic nicotinic acetylcholine receptors in rat striatum. The Journal Pharmacology and Experimental Therapeutics, 302(1), 197–204.
Mugnaini, M., Garzotti, M., Sartori, I., Pilla, M., Repeto, P., Heidbreder, C. A., et al. (2006). Selective down-regulation of [125I]-alpha-conotoxin mii binding in rat mesostriatal dopamine pathway following continuous infusion of nicotine. Neuroscience, 137(2), 565–572.
Nakayama, H., Numakawa, T., Ikeuchi, T., & Hatanaka, H. (2001). Nicotine-induced phosphorylation of extracellular signal-regulated protein kinase and CREB in PC12h cells. The Journal of Neurochemistry, 79(3), 489–498.
Naqvi, N. H., Rudrauf, D., Damasio, H., & Bechara, A. (2007). Damage to the insula disrupts addiction to cigarette smoking. Science, 315(5811), 531–534.
Olausson, P., Jentsch, J. D., & Taylor, J. R. (2003). Repeated nicotine exposure enhances reward-related learning in the rat. Neuropsychopharmacology, 28(7), 1264–1271.
Olausson, P., Jentsch, J. D., & Taylor, J. R. (2004a). Nicotine enhances responding with conditioned reinforcement. Psychopharmacology (Berl), 171(2), 173–178.
Olausson, P., Jentsch, J. D., & Taylor, J. R. (2004b). Repeated nicotine exposure enhances responding with conditioned reinforcement. Psychopharmacology (Berl), 173(1–2), 98–104.
Palmatier, M. I., & Bevins, R. A. (2002). Examination of GABAergic and dopaminergic compounds in the acquisition of nicotine-conditioned hyperactivity in rats. Neuropsychobiology, 45(2), 87–94.
Palmatier, M. I., Peterson, J. L., Wilkinson, J. L., & Bevins, R. A. (2004). Nicotine serves as a feature-positive modulator of pavlovian appetitive conditioning in rats. Behavioural Pharmacology, 15(3), 183–194.
Pandey, S. C., Roy, A., Xu, T., & Mittal, N. (2001). Effects of protracted nicotine exposure and withdrawal on the expression and phosphorylation of the CREB gene transcription factor in rat brain. The Journal Neurochemistry, 77(3), 943–952.
Parker, S. L., Fu, Y., McAllen, K., Luo, J., McIntosh, J. M., Lindstrom, J. M., et al. (2004). Up-regulation of brain nicotinic acetylcholine receptors in the rat during long-term self-administration of nicotine: Disproportionate increase of the alpha6 subunit. Molecular Pharmacology, 65(3), 611–622.
Paterson, N. E., & Markou, A. (2005). The metabotropic glutamate receptor 5 antagonist MPEP decreased break points for nicotine, cocaine and food in rats. Psychopharmacology (Berl), 179(1), 255–261.
Paterson, N. E., Semenova, S., Gasparini, F., & Markou, A. (2003). The mGlur5 antagonist MPEP decreased nicotine self-administration in rats and mice. Psychopharmacology (Berl), 167(3), 257–264.
Pauly, J. R., Marks, M. J., Gross, S. D., & Collins, A. C. (1991). An autoradiographic analysis of cholinergic receptors in mouse brain after chronic nicotine treatment. The Journal Pharmacology and Experimental Therapeutics, 258(3), 1127–1136.
Perkins, K. A., Gerlach, D., Vender, J., Grobe, J., Meeker, J., & Hutchison, S. (2001). Sex differences in the subjective and reinforcing effects of visual and olfactory cigarette smoke stimuli. Nicotine & Tobacco Research, 3(2), 141–150.
Picciotto, M. R., Zoli, M., Rimondini, R., Lena, C., Marubio, L. M., Pich, E. M., et al. (1998). Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature, 391(6663), 173–177.
Pidoplichko, V. I., DeBiasi, M., Williams, J. T., & Dani, J. A. (1997). Nicotine activates and desensitizes midbrain dopamine neurons. Nature, 390(6658), 401–404.
Pidoplichko, V. I., Noguchi, J., Areola, O. O., Liang, Y., Peterson, J., Zhang, T., et al. (2004). Nicotinic cholinergic synaptic mechanisms in the ventral tegmental area contribute to nicotine addiction. Learning & Memory, 11(1), 60–69.
Rice, M. E., & Cragg, S. J. (2004). Nicotine amplifies reward-related dopamine signals in striatum. Nature Neuroscience, 7(6), 583–584.
Robbins, T. W., & Everitt, B. J. (2002). Limbic-striatal memory systems and drug addiction. Neurobiology of Learning and Memory, 78(3), 625–636.
Robinson, T. E., & Berridge, K. C. (1993). The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Research. Brain Research Reviews, 18(3), 247–291.
Robinson, T. E., & Berridge, K. C. (2001). Incentive-sensitization and addiction. Addiction, 96(1), 103–114.
Rose, J. E., & Behm, F. M. (2004). Extinguishing the rewarding value of smoke cues: Pharmacological and behavioral treatments. Nicotine & Tobacco Research, 6(3), 523–532.
Rowell, P. P., & Duggan, D. S. (1998). Long-lasting inactivation of nicotinic receptor function in vitro by treatment with high concentrations of nicotine. Neuropharmacology, 37(1), 103–111.
Rowell, P. P., & Hillebrand, J. A. (1994). Characterization of nicotine-induced desensitization of evoked dopamine release from rat striatal synaptosomes. The Journal Neurochemistry, 63(2), 561–569.
Russell, M. A. (1989). Subjective and behavioural effects of nicotine in humans: Some sources of individual variation. Progress in Brain Research, 79, 289–302.
Salminen, O., Murphy, K. L., McIntosh, J. M., Drago, J., Marks, M. J., Collins, A. C., et al. (2004). Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. Molecular Pharmacology, 65(6), 1526–1535.
Salminen, O., Whiteaker, P., Grady, S. R., Collins, A. C., McIntosh, J. M., & Marks, M. J. (2005). The subunit composition and pharmacology of alpha-conotoxin MII-binding nicotinic acetylcholine receptors studied by a novel membrane-binding assay. Neuropharmacology, 48(5), 696–705.
Schiltz, C. A., Kelley, A. E., & Landry, C. F. (2005). Contextual cues associated with nicotine administration increase arc mrna expression in corticolimbic areas of the rat brain. European Journal of Neuroscience, 21(6), 1703–1711.
Schiltz, C. A., Kelley, A. E., & Landry, C. F. (2007). Acute stress and nicotine cues interact to unveil locomotor arousal and activity-dependent gene expression in the prefrontal cortex. Biological Psychiatry, 61(1), 127–135.
Schochet, T. L., Kelley, A. E., & Landry, C. F. (2005). Differential expression of arc mrna and other plasticity-related genes induced by nicotine in adolescent rat forebrain. Neuroscience, 135(1), 285–297.
Schroeder, B. E., Binzak, J. M., & Kelley, A. E. (2001). A common profile of prefrontal cortical activation following exposure to nicotine- or chocolate-associated contextual cues. Neuroscience, 105(3), 535–545.
Schultz, W. (2002). Getting formal with dopamine and reward. Neuron, 36(2), 241–263.
Shiffman, S., Paty, J. A., Gnys, M., Kassel, J. A., & Hickcox, M. (1996). First lapses to smoking: Within-subjects analysis of real-time reports. Journal of Consulting and Clinical Psychology, 64(2), 366–379.
Shoaib, M., Stolerman, I. P., & Kumar, R. C. (1994). Nicotine-induced place preferences following prior nicotine exposure in rats. Psychopharmacology (Berl), 113(3–4), 445–452.
Silva, A. J., Kogan, J. H., Frankland, P. W., & Kida, S. (1998). CREB and memory. Annual Review of Neuroscience, 21, 127–148.
Sorenson, E. M., Shiroyama, T., & Kitai, S. T. (1998). Postsynaptic nicotinic receptors on dopaminergic neurons in the substantia nigra pars compacta of the rat. Neuroscience, 87(3), 659–673.
Sparks, J. A., & Pauly, J. R. (1999). Effects of continuous oral nicotine administration on brain nicotinic receptors and responsiveness to nicotine in C57BL/6 mice. Psychopharmacology (Berl), 141(2), 145–153.
Svensson, T. H., Grenhoff, J., & Engberg, G. (1990). Effect of nicotine on dynamic function of brain catecholamine neurons. Ciba Foundation Symposium, 152, 169–180; discussion 180–165.
Sweatt, J. D. (2004). Mitogen-activated protein kinases in synaptic plasticity and memory. Current Opinion in Neurobiology, 14(3), 311–317.
Tapper, A. R., McKinney, S. L., Nashmi, R., Schwarz, J., Deshpande, P., Labarca, C., et al. (2004). Nicotine activation of alpha4* receptors: Sufficient for reward, tolerance, and sensitization. Science, 306(5698), 1029–1032.
Taylor, J. R., & Robbins, T. W. (1984). Enhanced behavioural control by conditioned reinforcers following microinjections of d-amphetamine into the nucleus accumbens. Psychopharmacology (Berl), 84(3), 405–412.
Taylor, J. R., & Robbins, T. W. (1986). 6-hydroxydopamine lesions of the nucleus accumbens, but not of the caudate nucleus, attenuate enhanced responding with reward-related stimuli produced by intra-accumbens d-amphetamine. Psychopharmacology (Berl), 90(3), 390–397.
Tiffany, S. T., & Drobes, D. J. (1990). Imagery and smoking urges: The manipulation of affective content. Addictivity Behaviors, 15(6), 531–539.
Valjent, E., Pages, C., Herve, D., Girault, J. A., & Caboche, J. (2004). Addictive and non-addictive drugs induce distinct and specific patterns of erk activation in mouse brain. European Journal Neuroscience, 19(7), 1826–1836.
Walters, C. L., Brown, S., Changeux, J. P., Martin, B., & Damaj, M. I. (2006). The beta2 but not alpha7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice. Psychopharmacology (Berl), 184(3–4), 339–344.
Walters, C. L., Cleck, J. N., Kuo, Y. C., & Blendy, J. A. (2005). Mu-opioid receptor and CREB activation are required for nicotine reward. Neuron, 46(6), 933–943.
Waters, A. J., Shiffman, S., Bradley, B. P., & Mogg, K. (2003). Attentional shifts to smoking cues in smokers. Addiction, 98(10), 1409–1417.
Wooltorton, J. R., Pidoplichko, V. I., Broide, R. S., & Dani, J. A. (2003). Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas. The Journal Neuroscience, 23(8), 3176–3185.
Wu, J., George, A. A., Schroeder, K. M., Xu, L., Marxer-Miller, S., Lucero, L., et al. (2004). Electrophysiological, pharmacological, and molecular evidence for alpha7-nicotinic acetylcholine receptors in rat midbrain dopamine neurons. The Journal of Pharmacology and Experiemntal Therapeuics, 311(1), 80–91.
Zhang, H., & Sulzer, D. (2004). Frequency-dependent modulation of dopamine release by nicotine. Nature Neuroscience, 7(6), 581–582.
Acknowledgement
This work was supported by grants DA00436, DA10455, DA14241 and AA15632 from the National Institutes of Health and by NARSAD.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Brunzell, D.H., Picciotto, M.R. (2008). Molecular Mechanisms Underlying the Motivational Effects of Nicotine. In: Caggiula, A., Bevins, R. (eds) The Motivational Impact of Nicotine and its Role in Tobacco Use. Nebraska Symposium on Motivation, vol 55. Springer, New York, NY. https://doi.org/10.1007/978-0-387-78748-0_3
Download citation
DOI: https://doi.org/10.1007/978-0-387-78748-0_3
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-78748-0
Online ISBN: 978-0-387-78749-7
eBook Packages: Behavioral ScienceBehavioral Science and Psychology (R0)